Physician profile
Krystal Daitz
NPI 1275011884
$6,620.24
in general payments reported to CMS, 2019-2025
20 companies · $1,404 in 2025
The $1,404 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $560 · 2023: $3,851 · 2024: $805 · 2025: $1,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,143 · Travel and Lodging: $2,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,142.78 |
| Travel and Lodging | $2,917.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,732.15 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $1,530.91 | 2023 | Omnia, Senza |
| Collegium Pharmaceutical, INC. | $823.93 | 2022-2025 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $465.54 | 2025 | Sprint Pns System |
| Abbott Laboratories | $433.45 | 2023-2025 | Proclaim, Eterna |
| Stimwave Technologies Incorporated | $298.96 | 2022 | |
| Nalu Medical, INC. | $276.03 | 2023-2025 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $260.74 | 2022-2025 | Relistor |
| Globus Medical, INC. | $137.84 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $126.10 | 2023-2024 | Ztlido |
| Saluda Medical Americas, INC. | $118.03 | 2023-2024 | Evoke Scs, Evoke |
| Vertex Pharmaceuticals Incorporated | $86.45 | 2025 | |
| Averitas Pharma INC. | $84.41 | 2023-2025 | Qutenza |
| Azurity Pharmaceuticals, INC. | $62.55 | 2023 | Horizant |
| Curonix LLC | $39.76 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $35.75 | 2023 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $34.70 | 2025 | Prospera |
| Ibsa Pharma INC. | $31.60 | 2025 | Licart, Flector, Tirosint |
| Bioventus LLC | $26.30 | 2023 | Supartz Fx Sodium Hyaluronate |
| Valinor Pharma, LLC | $15.04 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystal Daitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.